Efficacy results from the ToGA trial : a phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC)
収録刊行物
-
- J Clin Oncol (Meeting Abstracts)
-
J Clin Oncol (Meeting Abstracts) 27 LBA4509-, 2009